SALUBER SK s.r.o.
- Address
- Piestanska Ulica 5, 915 01 Nové Mesto nad Váhom, Slovakia
Digestive System Diseases
At SALUBER SK s.r.o., clinical research in Digestive System Diseases focuses on the effects of treatment on the gut environment during antibiotic therapy, particularly in patients with erythema migrans linked to early Lyme borreliosis. The work is aimed at understanding how supportive therapies may help protect intestinal balance while patients receive antibiotics.
- Studying patients undergoing antibiotic treatment for early Lyme borreliosis
- Evaluating ways to support and preserve gut microbiota
- Assessing the impact of Saccharomyces boulardii and related treatment approaches
This area of research is centered on improving treatment tolerance and exploring how to maintain digestive health during infection-related care.
Virus Diseases
The site also conducts research in Virus Diseases, with a focus on COVID-19 in adults and adolescents who are not hospitalized but are at higher risk of developing severe illness. These studies are designed to evaluate whether new antiviral treatments can help reduce the chance of worsening disease.
- Focusing on COVID-19 in participants at risk for more serious illness
- Testing a potential new antiviral therapy against placebo
- Assessing treatment effectiveness in the outpatient setting
Research at SALUBER SK s.r.o. in this field aims to support better care for people with viral infections before hospitalization becomes necessary.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Biocodex1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SALUBER SK s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Microbiota in Patients with Erythema Migrans Undergoing Antibiotic Therapy | Biocodex | Phase III | Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 1 | Unknown | 2024-06-18 | 2024-06-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.